Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0185869 ANTI-CSF1R ANTIBODIES FOR TREATING PVNS
Methods of treating pigmented villonodular synovitis (PVNS) with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided.
2016/0185868 OSTEOARTHRITIS TREATMENT
The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA). In accordance with the present invention, an...
2016/0185867 Use of c-Fms antagonists
The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA) and/or pain. In accordance with the present...
2016/0185866 METHODS FOR TREATING CHRONIC SINUSITIS WITH NASAL POLYPS BY ADMINISTERING AN IL-4R ANTAGONIST
The present invention provides methods for decreasing a nasal polyp score in a subject. The methods include administering to a subject in need thereof a...
2016/0185865 AFFINITY MATURED ANTI-CCR4 HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE
The present invention provides affinity matured humanized monoclonal antibodies, bi-specific antibodies, antibody conjugates, and fusion proteins that bind to...
2016/0185864 METHODS OF TREATING FGFR3 RELATED CONDITIONS
Provided herein are biomarkers and therapies for the treatment of pathological conditions, such as cancer, and method of using FGFR3 antagonists. In...
2016/0185863 COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
The present invention provides a newly identified B7 receptor, zB7R1 that functions as lymphocyte inhibitory receptor, which is a PD-1-like molecule and is...
2016/0185862 CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF
The present disclosure provides a heterodimeric, conditionally active chimeric antigen receptor (CAR), and a nucleic acid comprising a nucleotide sequence...
2016/0185861 METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR -EXPRESSING CELLS
The invention provides methods of making immune effector cells (e.g., T cells, NK cells) that can be engineered to express a chimeric antigen receptor (CAR),...
2016/0185860 MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER
The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLD18, including...
2016/0185859 ANTI-5T4 ANTIBODIES AND USES THEREOF
Anti-5T4 antibodies, anti-5T4 antibody/drug conjugates, and methods for preparing and using the same.
2016/0185858 Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well...
2016/0185857 NOVEL ANTI-FC-GAMMA RECEPTOR IIB ANTIBODIES AND USES THEREOF
The present invention provides an anti-FcyRIIB antibodies which, in comparison to prior art antibodies, markedly increase ITIM phosphorylation of FcyRIIB and...
2016/0185856 Anti-Claudin 1 Antibodies and Uses Thereof
The present invention relates to anti-claudin 1 antibodies and their uses thereof. In particular, the present invention relates to an anti-Claudin 1 (CLDN1)...
2016/0185855 ANTI-LRP5 ANTIBODIES AND METHODS OF USE
The invention provides anti-LRP5 antibodies and methods of making and using the same.
2016/0185854 AGENTS TARGETING CD138 AND USES THEREOF
Disclosed is a human murine chimeric antibody which substantially retains the antigen binding region of its murine counterpart and displays improved binding...
2016/0185853 CANCER TREATMENT USING ANTIBODIES THAT BIND CELL SURFACE GRP78
This application provides, inter alia, antibodies or antigen-binding fragments thereof, targeting cell surface GRP78 expressed on tumor cells, tumor...
2016/0185852 ANTI-NOTCH3 ANTIBODIES
Monoclonal antibodies that bind and inhibit activation of human Notch3 are disclosed. The antibodies can be used to treat cell proliferative diseases and...
2016/0185851 ANTIBODIES TO INTERLEUKIN-6 AND USE THEREOF
The present disclosure provides antibodies that bind to human interleukin-6 (IL6). The antibodies can modulate IL6 signaling and thus used in treatment or...
2016/0185850 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF ALPHA
The present invention relates to particularly stable and soluble scFv antibodies and Fab fragments specific for TNF.alpha., which comprise specific light chain...
2016/0185849 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING IDIOPATHIC INFLAMMATORY BOWEL DISEASE
Multiple-variable dose methods for treating TNF.alpha.-related disorders, including Crohn's disease and psoriasis, comprising administering TNF.alpha....
2016/0185848 METHODS FOR MODULATING THE GLYCOSYLATION PROFILE OF RECOMBINANT PROTEINS USING SUGARS
The present invention relates to the field of protein production, and in particular to methods and compositions for modulating glycosylation of recombinant...
2016/0185847 USE OF MONOCLONAL ANTIBODIES FOR THE TREATMENT OF INFLAMMATION AND BACTERIAL INFECTIONS
A composition includes monoclonal antibodies directed against a circulating proinflammatory cytokine, the antibodies having a high affinity for the...
2016/0185846 ANTIBODIES AGAINST MONOCYTE CHEMOTACTIC PROTEINS
The invention provides antibodies that bind to a plurality of .beta.-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The...
2016/0185845 METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK,...
Disclosed herein are methods for treating a vascular leak disorder, hypotension, or a procoagulant state using angiopoietin-2 (Ang-2) antagonist compounds....
2016/0185844 MODULATION OF SYNAPTIC MAINTENANCE
C1q is shown to be expressed in neurons, where it acts as a signal for synapse elimination. Methods are provided for protecting or treating an individual...
2016/0185843 TREATING ALCOHOL-MEDIATED DISORDERS BY INHIBITION OF RGS6
The invention provides RGS6 antagonists and methods for their use in treating the effects of alcohol consumption.
2016/0185842 14-3-3 Antagonists for the Prevention and Treatment of Arthritis
The invention provides compositions and methods for treating arthritis.
2016/0185841 METHOD FOR PURIFYING ANTIBODIES USING PBS
Disclosed here includes a method for purifying a biologic composition, comprising diafiltering the biologic composition into a composition comprising phosphate...
2016/0185840 RNA-CODED ANTIBODY
The present application describes an antibody-coding, non-modified or modified RNA and the use thereof for expression of this antibody, for the preparation of...
2016/0185839 POLYMERIC FORMS OF H-NOX PROTEINS
The invention provides polymeric H-NOX proteins for the delivery of oxygen with longer circulation half-lives compared to monomeric H-NOX proteins. Polymeric...
2016/0185838 Compositions and Methods for Diagnosing and Treating Cancer
The present invention relates to compositions and methods for characterizing, diagnosing, and treating cancer. In particular the invention provides the means...
2016/0185837 GIP AND GLP-1 RECEPTOR DUAL-AGONISTS FOR THE TREATMENT OF DIABETES
This disclosure provides GIP/GLP-1 dual agonist polypeptides for the treatment of hypoglycemic conditions, e.g., type-2 diabetes.
2016/0185836 METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS WITH FOLLISTATIN POLYPEPTIDES
The disclosure provides, in part, follistatin polypeptides that are suitable for use in local administration and methods for use.
2016/0185835 IMMUNE SYSTEM MEDIATOR
The present invention discloses an isolated nucleic acid molecule encoding an ISRAA polypeptide comprising at least 70% homology to the sequence represented by...
2016/0185834 PROTEIN ENGINEERED SYSTEMS FOR DELIVERY OF MOLECULES
Provided are compositions and methods for efficient delivery of polynucleotides and/or small molecules to or into cells. The compositions comprises a peptide...
2016/0185833 PEPTIDES
The present invention provides a peptide at least partially derivable from human Thyroid Stimulating Hormone Receptor (TSHR) which peptide is capable of...
2016/0185832 COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS RELATED TO CEP290
Compositions are provided that comprise a recombinant vector carrying a nucleic acid sequence encoding a fragment of CEP290 lacking all or part of its...
2016/0185831 NUCLEIC ACIDS FOR TREATMENT OF ALLERGIES
The present invention provides DNA vaccines for the treatment of allergies. The vaccines comprise the coding sequence for one or more allergenic epitopes, and...
2016/0185830 AXMI440 TOXIN GENE AND METHODS FOR ITS USE
Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding...
2016/0185829 Toxoid Peptides Derived from Phenol Soluble Modulin, Delta Toxin, Superantigens, and Fusions Thereof
The present disclosure provides immunogenic compositions useful in prevention and treatment of Staphylococcus aureus infection. In particular, the disclosure...
2016/0185828 Genetic Reprogramming of Bacterial Biofilms
Described herein are methods and compositions relating to engineered curii fibers, e.g. CsgA polypeptide. In some embodiments, the methods and compositions...
2016/0185827 VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS
The present invention stems from the finding that the interaction between the .beta.2 adrenoceptor (.beta.2AP) and type IV pilus-associated proteins initiates...
2016/0185826 VIRUS-LIKE PARTICLE VACCINES
The invention is directed to dimeric fusion proteins and virus-like particles comprising such dimeric fusion proteins. These dimeric fusion proteins comprise...
2016/0185825 ENGINEERED OUTER DOMAIN (EOD) OF HIV GP120 AND MUTANTS THEREOF
The invention relates to an engineered outer domain (eOD) of HIV gp120 and mutants thereof and methods of making and using the same. The mutant eODs may be...
2016/0185824 BETA SHEET TAPES RIBBONS IN TISSUE ENGINEERING
There is described a material comprising tapes, ribbons, fibrils or fibres characterized in that each of the ribbons, fibrils or fibres have an antiparallel...
2016/0185823 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS
The present invention provides antimicrobial polymyxin compounds of the following formula I: ##STR00001## or pharmaceutically acceptable salts, hydrates, or...
2016/0185822 CORTISTATIN ANALOGUES FOR THE TREATMENT OF INFLAMMATORY AND/OR IMMUNE DISEASES
The invention relates to cortistatin analogues and their uses. The compounds of the invention are peptide ligands with potential application in the diagnosis,...
2016/0185821 Z-SELECTIVE OLEFIN METATHESIS OF PEPTIDES
The invention relates generally to the synthesis of modified amino acids and modified peptides in the presence of cyclometalated catalysts. The invention has...
2016/0185820 PROTRANSDUZIN B, A GENE TRANSFER ENHANCER
An N-terminally protected peptide having the sequence TABLE-US-00001 (SEQ ID NO: 1) X-Glu-Cys-Lys-Ile-Lys-Gln-Ile-Ile-Asn-Met-Trp-Gln, wherein X is a group...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.